Topics
Gliomas | Treatment | Targeted therapy | Ulixertinib
Home > Publications > Topics > Gliomas > Treatment > Targeted therapy > Ulixertinib
Vo
KT, Sabnis AJ, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey B,
Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Jaju A, Fox E,
Weigel BJ, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway
KA, Seibel NL, Parsons DW.
Phase II
Study of Ulixertinib in Children and Young Adults With Tumors
Harboring Activating Mitogen-Activated Protein Kinase Pathway
Alterations: APEC1621J of the National Cancer Institute-Children's
Oncology Group Pediatric MATCH Trial.
JCO
Precis Oncol. 2024 Jun 27;8:e2400103. doi:
10.1200/PO.24.00103. PMID:
38935895. Interventional study˰
ˍ